Functional comparison of muscarinic partial agonists at muscarinic receptor subtypes hM1, hM2, hM3, hM4 and hM5 using microphysiometry

• Published in: British journal of pharmacology 1999-04, Vol.126 (7), p.1620-1624
• Main Authors: Wood, Martyn D, Murkitt, Karen L, Ho, Michael, Watson, Jeannette M, Brown, Frank, Hunter, A Jacqueline, Middlemiss, Derek N
• Format: Article
• Language: English
• Subjects: Animals; Biological and medical sciences; CHO Cells; Cholinergic system; Cricetinae; Humans; Medical sciences; microphysiometry; Muscarinic Agonists - pharmacology; Muscarinic receptor; Neuropharmacology; Neurotransmitters. Neurotransmission. Receptors; partial agonists; Pharmacology. Drug treatments; Quinuclidinyl Benzilate - metabolism; Radioligand Assay; Receptor, Muscarinic M1; Receptor, Muscarinic M2; Receptor, Muscarinic M3; Receptor, Muscarinic M4; Receptors, Muscarinic - drug effects; Receptors, Muscarinic - physiology; selectivity
• ISSN: 0007-1188; 1476-5381
• DOI: 10.1038/sj.bjp.0702463

This study describes the pharmacological comparison of the muscarinic partial agonists sabcomeline, xanomeline and milameline at human cloned muscarinic receptor subtypes (hM1–5). Radioligand binding studies at the hM1–5 muscarinic receptor subtypes were compared with functional studies using microphysiometry using carbachol as the standard full agonist. In binding assays none of the compounds studied displayed preferential affinity for the M1,3,4 or M5 subtypes although carbachol was less potent at hM1 than hM3,4,5. In functional studies, all of the compounds studied displayed similar levels of efficacy across the muscarinic receptors with the exception of M3, where there was a large apparent receptor reserve and the compounds behaved essentially as full agonists. Sabcomeline was the most potent agonist in functional studies but also showed the lowest efficacy. In terms of potency, xanomeline showed some selectivity for M1 over M2 receptors and milameline showed some selectivity for M2 over M1 receptors. These results show the value of microphysiometry in being able to compare receptor pharmacology across subtypes irrespective of the signal transduction pathway. None of the partial agonists showed functional selectivity for M1 receptors, or indeed any muscarinic receptor, in the present study. British Journal of Pharmacology (1999) 126, 1620–1624; doi:10.1038/sj.bjp.0702463